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Abstract
Motivation: Single-cell RNA sequencing (scRNA-seq) has revolutionized biological sciences by re-
vealing genome-wide gene expression levels within individual cells. However, a critical challenge
faced by researchers is how to optimize the choices of sequencing platforms, sequencing depths
and cell numbers in designing scRNA-seq experiments, so as to balance the exploration of the
depth and breadth of transcriptome information.
Results: Here we present a flexible and robust simulator, scDesign, the first statistical framework
for researchers to quantitatively assess practical scRNA-seq experimental design in the context of
differential gene expression analysis. In addition to experimental design, scDesign also assists
computational method development by generating high-quality synthetic scRNA-seq datasets
under customized experimental settings. In an evaluation based on 17 cell types and 6 different
protocols, scDesign outperformed four state-of-the-art scRNA-seq simulation methods and led to
rational experimental design. In addition, scDesign demonstrates reproducibility across biological
replicates and independent studies. We also discuss the performance of multiple differential ex-
pression and dimension reduction methods based on the protocol-dependent scRNA-seq data gen-
erated by scDesign. scDesign is expected to be an effective bioinformatic tool that assists rational
scRNA-seq experimental design and comparison of scRNA–seq computational methods based on
specific research goals.
Availability and implementation: We have implemented our method in the R package scDesign,
which is freely available at https://github.com/Vivianstats/scDesign.
Contact: jli@stat.ucla.edu
Supplementary information: Supplementary data are available at Bioinformatics online.
1 Introduction
The emergence and rapid development of single-cell RNA-
sequencing (scRNA-seq) technologies offer unprecedented opportu-
nities for investigating transcriptional mechanisms underlying
biological and medical phenomena at the individual-cell resolution
(Haque et al., 2017; Wagner et al., 2016). While bulk RNA sequenc-
ing has been widely used to capture the average transcriptome infor-
mation in a batch of cells (Li and Li, 2018b), scRNA-seq allows the
investigation of transcriptome variation across thousands to millions
of cells. The scRNA-seq technologies have enabled researchers to in-
vestigate fundamental biomedical questions, such as cellular com-
position of various tissues and cell types, cell differentiation
trajectories, and spatial and temporal dynamics of single cells.
Important discoveries have been made from scRNA-seq data and
have advanced our understanding of diseases, such as neurological
disorders (Skene et al., 2018) and tumorigenesis (Tirosh et al.,
2016).
Since the first scRNA-seq study was published in 2009 (Tang
et al., 2009), more than 20 scRNA-seq experimental protocols have
been developed. An effective experimental design requires careful
consideration of the target research question as well as the experi-
mental budget, and a typical design in practice consists of two steps.
First, researchers need to select a proper protocol among the avail-
able ones, and the primary consideration is the choice between a
tag-based protocol that allows the integration of unique molecular
identifiers (UMIs) (Kivioja et al., 2012) and a full-length protocol
that captures full-length transcripts and allows the addition of the
External RNA Control Consortium (ERCC) spike-ins (Bacher and
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Kendziorski, 2016). The tag-based protocols [e.g. Drop-seq
(Macosko et al., 2015)] are usually used to obtain a broad but shal-
low view of the transcriptomes across many cells, while the full-
length protocols [e.g. Smart-seq2 (Picelli et al., 2013)] provide a
deeper account of the gene expression in fewer cells. For example, a
study about gene expression dynamics during stem cell differenti-
ation requires accurate gene expression measurements, so it should
opt for a full-length protocol. In contrast, in a study aiming to iden-
tify a previously unknown cell phase during the differentiation, it is
necessary to sequence a large number of cells using a tag-based
protocol to capture the transient phases. In the second step, to opti-
mize an experiment with a selected protocol and a fixed budget,
researchers need to choose between exploring the depth or breadth
of transcriptome information, which sums up to determining the ap-
propriate number of cells to sequence.
However, in contrast to the classical experimental design (Quinn
and Keough, 2002) guided by certain theoretical optimality (e.g. the
maximum power of a statistical test), the scRNA-seq experimental
design is impeded by various sources of data noises, making a rea-
sonable theoretical analysis tremendously difficult (Kolodziejczyk
et al., 2015; Pierson and Yau, 2015). Especially, scRNA-seq data
are characterized by excess zeros resulted from dropout events, in
which a gene is expressed in a cell but its mRNA transcripts are un-
detected. As a result, many commonly used statistical assumptions
are not directly applicable to modeling scRNA-seq data. For ex-
ample, Baran-Gale et al. proposed using a Negative Binomial model
to estimate the number of cells to sequence, so that the resulting ex-
periment is expected to capture at least a specified number of cells
from the rarest cell type (Baran-Gale et al., 2017). However, the esti-
mation accuracy depends on the idealized Negative Binomial model
assumption, which real scRNA-seq data usually do not closely fol-
low (Supplementary Fig. S1). There is also a theoretical investigation
of the cell-depth trade-off based on the Poisson assumption of gene
read counts and a specific list of genes of interests (Zhang et al.,
2018). In contrast to model-based design approaches (Dumitrascu
et al., 2018), multiple scRNA-seq studies used descriptive statistics
to provide qualitative guidance instead of well-defined optimization
criteria for experimental design (Gru¨n and van Oudenaarden, 2015;
Rizzetto et al., 2017). However, because the descriptive statistics
were proposed from diverse perspectives, their resulting experimen-
tal designs are difficult to unify to guide practices. For example, one
study reported that the sensitivity of most protocols saturates at ap-
proximately one million reads per cell (Ziegenhain et al., 2017),
while another study found that the saturation occurs at around 4.5
million reads per cell (Svensson et al., 2017). The reason for this dis-
crepancy is that the two studies defined the sensitivity in different
ways: the first study used the gene detection rate, while the second
study used the minimum number of input RNA molecules required
for confidently detecting a spike-in control (Jiang et al., 2011).
In this article, we propose a statistical simulator scDesign for
optimizing scRNA-seq experimental design from the perspective of
detecting differentially expressed (DE) genes between two biological
conditions (determined before an experiment) or two cell states
(inferred after an experiment), a major scRNA-seq data analysis
task. Given a pre-defined significance level [e.g. a false discovery
rate (FDR)], the power of an scRNA-seq experiment for detecting
DE genes is jointly determined by the sensitivity of detecting gene
expression, the accuracy of measuring gene expression and the num-
ber of cells sequenced for each cell state. For each protocol and a
specified total sequencing depth (i.e., the total number of reads in an
scRNA-seq experiment), the cell-wise sequencing depth (i.e. the
expected number of reads per cell) decreases as the cell number
increases (Haque et al., 2017). However, existing power analysis
methods for scRNA-seq experiments unrealistically assume a fixed
cell-wise sequencing depth, which does not change as the cell num-
ber varies (Vieth et al., 2017; Ziegenhain et al., 2017). Therefore,
the practical scRNA-seq experimental design calls for a new ap-
proach that accounts for various characteristics and constraints of a
real scRNA-seq experiment.
ScDesign is a simulation-based experimental design framework
that has multiple advantages in real practice. First, scDesign is
protocol- and data-adaptive. It learns scRNA-seq data characteris-
tics from rapidly accumulating public scRNA-seq data generated
under diverse settings. For example, 1976 series of scRNA-seq data-
sets are currently available in the Gene Expression Omnibus (GEO)
database (Edgar et al., 2002). There are also newly developed
scRNA-seq databases, such as SCPortalen (70 studies with 67 146
cells) (Abugessaisa et al., 2018), scRNASeqDB (36 studies with
8910 cells) (Cao et al., 2017) and the Single Cell Portal (43 studies
with 496 366 cells). Second, scDesign generates synthetic data that
well mimic real scRNA-seq data under the same experimental set-
tings, providing a basis for using its synthetic data to guide practical
scRNA-seq experimental design. Third, scDesign is flexible in
accommodating user-specific analysis needs. Users can apply
scDesign to evaluate the performance of downstream analysis, such
as gene differential expression and cell clustering, under various ex-
perimental settings at no experimental cost. Assisted by the evalu-
ation results, users will be able to design an scRNA-seq experiment
based on the setting that leads to the best performance according to
their specified criteria.
2 Materials and Methods
2.1 The statistical framework of scDesign
We develop scDesign based on a statistical generative framework
that utilizes both existing real scRNA-seq data and reasonable
assumptions mimicking various experimental processes. In contrast
to the existing simulation methods for scRNA-seq data, scDesign
constructs a Gamma-Normal mixture model to account for dropout
events. This is motivated by the successful applications of our previ-
ously developed imputation method, scImpute, for recovering drop-
out gene expression values in scRNA-seq data (Li and Li, 2018a).
This mixture model allows scDesign to overcome the dropout hurdle
in learning key gene expression characteristics from real scRNA-seq
data (Supplementary Fig. S1), so that scDesign generates synthetic
data highly similar to real data in multiple aspects. Depending on
whether the task is to design an scRNA-seq experiment to sequence
one or two batches of cells, scDesign has the corresponding one-
state mode (Supplementary Fig. S2a) or the two-state mode
(Supplementary Fig. S2b). In the one-state mode, scDesign leverages
the information in a real scRNA-seq dataset from one biological
condition (e.g. treatment or control) or one cell state (e.g. T cells) to
generate a single scRNA-seq dataset given an experimental setting,
i.e. a pre-specified total sequencing depth and a cell number. From
the real scRNA-seq dataset, scDesign first estimates two cell-wise
and three gene-wise parameters, which jointly define the key charac-
teristics of scRNA-seq data. Second, scDesign simulates ideal gene
expression levels for new cells of the same biological condition or
cell state based on the estimated gene expression parameters. Third,
scDesign introduces missing values to mimic the actual dropout
events in an scRNA-seq experiment. Fourth, scDesign outputs a syn-
thetic gene expression matrix with entries as read counts. In the
two-state mode, scDesign leverages the information in two real
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scRNA-seq datasets from different biological conditions or cell
states to generate two scRNA-seq datasets given an experimental
setting. In this two-state mode, the simulation by scDesign mimics
an experiment where two groups of cells from two biological condi-
tions or cell states are sequenced together (Supplementary Fig. S2b).
2.2 scDesign for scRNA-seq data simulation
In this section, we describe how scDesign generates simulated RNA-
seq data given existing real scRNA-seq data from a certain cell state.
These simulated count matrices capture the characteristics of real
count matrices, and they thus can be used to assist the development
of computational methods and evaluate the performance of those
methods under user-specified settings. We introduce how to simu-
late a single count matrix below. Please refer to the Supplementary
Material for simulating multiple count matrices following a differen-
tiation path.
Given a real single-cell count matrix with I genes and J0 cells,
our goal is to generate a new count matrix with I genes and J cells,
under the constraint that the new matrix has a total of S reads
(Supplementary Fig. S2a). Both J and S are user-specified parame-
ters. This resembles the real scenario where both the cell number
and the total read number (i.e. the total sequencing depth) need to
be specified before an scRNA-seq experiment.
2.2.1. Step 1: Estimate parameters from real scRNA-seq data
Denote the real single-cell count matrix by X real, whose I rows and
J0 columns represent the genes and cells, respectively. About the two
cell-wise parameters, for each cell j we estimated its library size as
s^0j ¼
XI
i¼1
Xrealij ; j ¼ 1; . . . ; J0;
and its cell-wise dropout rate as
q^0j ¼
1
I
XI
i¼1
I Xrealij ¼ 0
n o
; j ¼ 1; . . . ; J0:
Then we fit the cell library sizes s^01; . . . ; s^0J0 using a truncated
Normal distribution, and the estimated mean and standard devi-
ation (SD) are denoted as l^s and r^s, respectively.
To estimate the three gene-wise parameters, we first normalized
the read counts given their corresponding library sizes and then per-
formed a logarithmic transformation on the normalized values. The
transformed matrix is denoted as X log , where
X logij ¼ log 10
medianfs^01; . . . ; s^0Jg
s^0j
Xrealij þ 1:01
 !
:
Using the Gamma-Normal mixture model described in the
scImpute method (Li and Li, 2018a), we estimated the gene-wise
dropout rate and mean and SD of gene expression. The mixture
model considers the expression levels of gene i as independently and
identically distributed random variable X logi1 ; . . . ;X
log
iJ0
following the
density function
fiðxÞ ¼ k0iGammaðx; a0i; b0iÞ þ ð1  k0iÞNormalðx; l0i; r20iÞ;
where k0i is gene i’s dropout rate, a0i and b0i are the shape and rate
parameters of the Gamma distribution and l0i and r0i are the mean
and SD of the Normal distribution. The Gamma component
describes the gene expression distribution when dropout occurs,
while the Normal component represents the distribution of actual
gene expression levels. We use multiple real scRNA-seq datasets to
demonstrate that this mixture model outperforms the widely used
Negative Binomial model in terms of goodness of fit to real data
(Supplementary Fig. S1). The parameters in this model can be esti-
mated by the Expectation-Maximization (EM) algorithm and the
resulting dropout rate, mean and SD estimates are denoted as
k^0i; l^0i and r^0i, respectively. We then used a Gamma distribution to
fit the estimated gene mean expression levels l^01; . . . ; l^0I and
denoted the estimated shape and scale parameters as k^0 and h^0.
To summarize, we estimated two cell-wise parameters including
the cell library size s^0j and the cell-wise dropout rate q^0j
(j ¼ 1; . . . ; J0), and three gene-wise parameters including the mean
expression l^0i, the SD r^0i and the gene-wise dropout rate k^0i
(i ¼ 1; . . . ; I).
2.2.2. Step 2: Simulate ideal gene expression values
In this step, we simulated the ideal expression values independently
for each gene without considering varying cell library sizes and the
dropout issue. For each gene i (i ¼ 1; . . . ; I), we first simulated its
mean expression li  Gammaðk^0; h^0Þ, then we simulated its SD by
stratified sampling from the binned observations, which we proc-
essed from the real count matrix. Specifically, we divided the esti-
mated gene mean expression values fl^01; . . . ; l^0Ig into B intervals,
and we use l^0ðkÞ to denote the kth order statistic of fl^01; . . . ; l^0Ig.
Then, the first interval is 1; l^0ð1Þ þ l^0ðIÞl^0ð1ÞB
 i
, the bth interval
(1 < b < B) is l^0ð1Þ þ l^0ðIÞl^0ð1ÞB ðb 1Þ; l^0ð1Þ þ
l^0ðIÞl^0ð1Þ
B b
 i
and the
Bth interval is l^0ð1Þ þ l^0ðIÞl^0ð1ÞB ðB 1Þ;þ1
 i
. We define z^0i ¼ b if
l^0i belongs to the bth bin, and similarly we define zi ¼ b if li
belongs to the bth bin. We simulated the SD ri of gene i by sampling
from the stratified gene SDs estimated from the real
data: ri  Uniformðfr^0i0 : z^0i0 ¼ zi; i0 ¼ 1; . . . ; IgÞ. Finally, we
generated the ideal expression matrix X ideal, where Xidealij i:i:d:
Normalðli; r2i Þ; j ¼ 1; . . . ; J.
2.2.3. Step 3: Introduce dropout events
In this step, we introduced dropout events into the synthetic count
matrix, while accounting for the variability of both gene-wise and
cell-wise dropout rates. The cell-wise dropout rate in a synthetic cell
j was simulated as qj i:i:d: Uniformðfq^01; . . . ; q^0J0gÞ; j ¼ 1; . . . ; J. For
each gene i (i ¼ 1; . . . ; I), we simulated its gene-wise dropout rate ki
by sampling one value from the stratified dropout rates estimated
from the real data: ki  Uniformðfk^0i0 : z^0i0 ¼ zi; i0 ¼ 1; . . . ; IgÞ.
Then, we simulated the number of dropout events of gene i:
ni  BinomialðJ; kiÞ. In other words, gene i was affected by the drop-
out events in ni cells. These ni cells were sampled without replace-
ment from the cell population f1;2; . . . ; Jg, with cell j being selected
with probability
qjPJ
j¼1 qj
. We denote the sampling results by Iij, with
Iij ¼ 1 indicating that gene i is a dropout in cell j and Iij ¼ 0 indicat-
ing that gene i is successfully amplified in cell j, j ¼ 1; . . . ; J. Then
we obtained the synthetic count matrix with dropout events Xdrop,
where Xdropij ¼ ½10X
ideal
ij
IfIij¼0g  1:01; and ½x is the nearest integer
to x.
2.2.4. Step 4: Simulate the final count matrix
We first simulated the library size of each synthetic cell j:
sj i:i:d:Normalðl^s; r^2s Þ; j ¼ 1; . . . ; J, and then we calculated the
expected proportion of each entry in the count matrix
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Pij ¼
sjX
drop
ijPI
i¼1
PJ
j¼1 sjX
drop
ij
:
Finally, we obtained the final synthetic count matrix Xsyn, which
is constrained by the sequencing depth S, by simulating its counts
from the multinomial distribution: ðXsyn11 ; . . . ;Xsyn1J ; . . . ; XsynI1 ; . . . ;
XsynIJ Þ  Multinomial

S; ðP11; . . . ;P1J; . . . ;PI1; . . . ;PIJÞ

:
2.3 scDesign for scRNA-seq experimental design
ScDesign aims to determine the best number of cells to sequence
given a fixed sequencing depth, such that the resulting RNA-seq
data are optimized for differential gene expression analysis. We de-
note the two real count matrices as Xreal1, with I rows (genes) and
J01 columns (cells), and X
real2, with I rows (genes) and J02 columns
(cells). Without loss of generality, we assume that the two matrices,
which represent two cell states, have the same genes listed in the
same order. We introduce how to simulate a synthetic count matrix
for each state with scDesign in two scenarios, and the procedure is
then repeated with varying cell numbers to obtain synthetic data for
power analysis (Supplementary Material).
2.3.1 Scenario (1)
In scenario (1), we assume that cells from the two cell states are pre-
pared as separate libraries and sequenced independently. Given
Xreal1 and Xreal2, the goal of scDesign is to generate a synthetic count
matrix with I genes and J1 cells for state 1, and a synthetic count ma-
trix with I genes and J2 cells for state 2. Cell states 1 and 2 have
sequencing depths of S1 and S2, respectively. For each state
g ðg ¼ 1;2Þ, we follow Section 2.2 to simulate a count matrix Xsyn;gIJg .
The only difference is in step 2, where we directly set lgi ¼ l^g0i and
rgi ¼ r^g0i; i ¼ 1; . . . ; I, instead of simulating new parameters. This is
to ensure that the rows in the two simulated matrices still represent
the same set of real genes, and the power analysis based on the simu-
lated data is biologically meaningful.
2.3.2 Scenario (2)
Now we consider the case where the two cell states are jointly
sequenced. Suppose that the two cell states are mixed in one bio-
logical sample, and the experimental setting is that J cells are to be
sequenced to generate S RNA-seq reads in total. We assume that the
two cell states present in fractions of p1 and p2 in the sample, re-
spectively. That is, 0 < p1 < 1; 0 < p2 < 1 and p1 þ p2  1.
When p1 þ p2 < 1, there are more than two cell states present in
the same sample. The goal of scDesign in scenario (2) is to simulate
count matrices for the two selected cell states, based on a real count
matrix of each state (Supplementary Fig. S2b).
1. Determine cell numbers.
We denote the numbers of cells from state 1, state 2 and
the remaining states as J1, J2 and Jr, respectively. These numbers
were sampled from a Multinomial distribution:
ðJ1; J2; JrÞ  Multinomial

J; ðp1;p2; 1  p1  p2Þ

:
2. Simulate count matrices with dropout events.
Following steps 1–3 in Section 2.2, we simulated two count
matrices Xdrop1IJ1 and X
drop2
IJ2 for cell states 1 and 2, respectively. The
only difference is in step 2, where we directly set lgi ¼ l^g0i and
rgi ¼ r^g0i; i ¼ 1; . . . ; I, to ensure that the rows in the synthetic count
matrices represent the same set of real genes.
3. Simulate the final count matrices.
We first simulated the library sizes of the cells in the two states:
s1j  Normal

l^1s ; ðr^1s Þ2

; j ¼ 1; . . . ; J1;
s2j  Normal

l^2s ; ðr^2s Þ2

; j ¼ 1; . . . ; J2;
where l^1s and r^
1
s are estimated from X
real1, and l^2s and r^
2
s are esti-
mated from Xreal2. Then we combined the two count matrices to ob-
tain the expected proportion matrix PIðJ1þJ2Þ:
Pij ¼ ZijPI
i¼1
PJ1
j0¼1 s
1
j0X
drop 1
ij0 þ
PI
i¼1
PJ2
j00¼1 s
2
j00X
drop 2
ij00
;
where Zij ¼ s1j Xdrop 1ij if 1  j  J1, and Zij ¼ s2jJ1X
drop 2
iðjJ1Þ if
J1 < j  J1 þ J2. The first J1 columns and the last J2 columns in P
give the expected proportions of genes in cell states 1 and 2, respect-
ively. We further assume that the total number of reads from the
two states together is S0 ¼ ½SðJ1 þ J2Þ=J, where ½x denotes the near-
est integer to x. Then we simulated the final count matrix X synIðJ1þJ2Þ
constrained by the sequencing depth from a Multinomial distribu-
tion: ðX syn11 ; . . . ;X syn1ðJ1þJ2Þ; . . . ;X
syn
I1 ; . . . ;X
syn
IðJ1þJ2ÞÞ  Multinomial

S0;
ðP11; . . . ;P1ðJ1þJ2Þ; . . . ;PI1; . . . ;PIðJ1þJ2ÞÞ

: The final count matrix of
cell state 1 and state 2 are X
syn;1
IJ1 (X
syn;1
ij ¼ Xsynij ) and X syn;2IJ2
Xsyn;2ij ¼ XsyniðjþJ1Þ

, respectively.
3 Results
3.1 scDesign captures key characteristics of scRNA-seq
data
We first demonstrate that scDesign accurately captures six key char-
acteristics of real scRNA-seq data, so it serves as a reliable data
simulator to assist scRNA-seq experimental design and to compare
relevant computational methods. To assess the simulation perform-
ance of scDesign as compared with four other simulation methods,
splat, powsimR, Lun and scDD, we compared the simulated data
generated by each method with the real data from various protocols.
Both splat and powsimR are software packages for simulating
scRNA-seq data (Vieth et al., 2017; Zappia et al., 2017); Lun
denotes the simulation design introduced by Lun et al. (Lun et al.,
2016); scDD denotes the simulation method designed to evaluate
the DE method scDD (Korthauer et al., 2016). We considered six
experimental protocols: Smart-seq2 (Picelli et al., 2013), Drop-seq
(Macosko et al., 2015), 10x Genomics (Zheng et al., 2017),
Fluidigm C1 (SMARTer) (Pollen et al., 2014), inDrop (Klein et al.,
2015) and Seq-Well (Gierahn et al., 2017), and we collected three
real scRNA-seq gene expression datasets of distinct cell types from
each protocol (Supplementary Table S1). In summary, we used 18
real count matrices of 17 cell types from human and mouse to evalu-
ate the five simulation methods.
For each real count matrix, we randomly split the columns (cells)
into two subsets of equal sizes, one used to estimate gene expression
parameters and simulate a new count matrix with the same dimen-
sions, and the other used to evaluate the simulation results. We com-
pared each pair of real and simulated count matrices in terms of six
summary statistics, including four gene-wise statistics [the count
mean, the count variance, the count coefficient of variation (cv) and
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the gene-wise zero proportion) and two cell-wise statistics (the li-
brary size and the cell-wise zero proportion) (Supplementary
Material). Our results show that scDesign well mimics real scRNA-
seq experiments based on all the six experimental protocols, even
though those protocols generate data with distinct properties. For
example, data from Smart-seq2 and Fluidigm C1 have relatively
larger library sizes and smaller count cvs (Fig. 1a and
Supplementary Figs S3 and S4), while data from the other four pro-
tocols have smaller library sizes and larger zero proportions
(Supplementary Figs S5–S8). We measured the similarity between
each summary statistics’ empirical distributions in real and the cor-
responding simulated data by each simulation method, using the
Kolmogorov–Smirnov (KS) distance, whose value is between 0 and
1 and a smaller value indicates greater similarity (Supplementary
Material). Comparing the KS distances of the five methods, we
found that scDesign performs the best for five protocols: Smart-
seq2, Fluidigm C1, Seq-Well, Drop–seq and inDrop (Fig. 1b and
Supplementary Figs S3–S5, S7 and S8), while scDesign and
powsimR perform comparably for 10x Genomics (Supplementary
Fig. S6). In summary, scDesign is ranked the best in 84 comparisons
and the second best in 20 comparisons, among all the 108 compari-
sons (6 statistics for each of the 18 datasets). In addition, our results
also show that scDesign is able to preserve the relationships between
genes’ expression mean and expression variance, expression cv and
zero proportion (Fig. 1c). The demonstrated advantage of scDesign
is rooted in its ability to incorporate both parametric and non-
parametric methods to simulate scRNA-seq data. By constructing a
mixture model to account for the dropout events, scDesign explicitly
models the gene-wise parameters from the real data. When generat-
ing cell-wise parameters for the simulated cells, scDesign uses differ-
ent sampling techniques for each parameter to capture its
distribution characteristic. In terms of the method stability,
scDesign, Lun and splat successfully estimated simulated data for all
the 18 datasets, while scDD encountered errors with 5 datasets, and
powsimR had errors with 4 datasets.
3.2 scDesign guides rational scRNA-seq experimental
design
Given a fixed sequencing depth in designing an scRNA-seq experi-
ment, scDesign assists users in predicting the optimal number of cells
for sequencing. In the context of gene differential expression ana-
lysis of two cell states, the cell number is optimal if its resulting
scRNA-seq data lead to the most accurate detection of DE genes,
where the accuracy depends on a user-specified criterion, e.g. a stat-
istical test’s power given a significance level. We consider two scen-
arios: (1) cells from the two cell states are prepared as two separate
libraries and sequenced independently; (2) cells from the two cell
states are prepared in the same library and sequenced together.
Scenario (1) includes many studies that investigated cells collected at
two differentiating time points, cells of the same tissue type from
patients and healthy subjects or cells of the same type but exposed
to different experimental treatments (Jaitin et al., 2014; Shekhar
et al., 2016). The experimental design under scenario (1) aims to se-
lect the optimal cell numbers simultaneously for two libraries, so
that the subsequent DE analysis becomes the most accurate given a
user-specified criterion. Scenario (2) includes many scRNA-seq stud-
ies that sequenced an in vivo tissue sample, e.g. the peripheral blood
mononuclear cell sample (Zheng et al., 2017), which is composed of
a mixture of cell subtypes. In scenario (2), DE analysis is performed
on a pair of known or putative cell subtypes within the sequenced
sample. We consider the experimental design to optimize the DE
analysis between two pre-selected cell subtypes under scenario (2).
In scenario (1), the constraints are the total sequencing depths of
the two cell states, and scDesign aims to determine the optimal cell
number for each cell state, among a set of candidate cell numbers.
ScDesign simulates a new count matrix of each state based on a real
count matrix of the same state, for each pre-specified sequencing
depth and cell number. Once obtaining the simulated count matrices
corresponding to various candidate cell numbers, scDesign assesses
the accuracy of DE gene identification using five measures: preci-
sion, recall, true negative rate, F1 score (the harmonic mean of
(a)
(c)
(b)
Fig. 1. Comparison of scRNA-seq simulation methods based on the Smart-seq2 protocol. (a) The gene-wise expression mean, expression variance, expression
coefficient of variation, zero proportion and the cell-wise zero proportion and library size in both real (monocytes) and simulated datasets. (b) The KS distances
between the six statistics in the real and simulated data. The best and second best simulation methods with respect to each statistic are respectively marked with
1 and 2 in the heatmaps. (c) The empirical relationships between the key statistics in the real and simulated data
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precision and recall) and F2 score (the harmonic mean of true nega-
tive rate and recall) (Supplementary Table S2). We applied scDesign
to optimize the designs of 14 example experiments (Supplementary
Table S3). In every experiment, we set the sequencing depth to 100
million reads, and considered eight candidate cell numbers per cell
state: 64, 128, 256, 512, 1024, 2048, 4096 and 8192. The DE genes
between two cell states were identified using the two-sample t-test.
Our results suggest that given a selected criterion in the DE ana-
lysis, the optimal cell number is jointly determined by multiple tech-
nical factors, including the experimental protocol and the variation
introduced by sequencing, as well as biological factors, such as the
intra- and inter-state cellular heterogeneity. Two factors are notable.
First, when cells of the same two states are sequenced, the optimal
cell number varies with protocols. For example, between two sub-
types of glial cells: astrocytes and oligodendrocytes, 512 cells per
state is the optimal cell number that maximizes the recall in DE ana-
lysis when Fluidigm C1 is used, but the number becomes 4096 per
state when inDrop is used (Fig. 2). If users choose the F1 score as the
criterion, the optimal cell number per state is 128 and 1024 for
Fluidigm C1 and inDrop, respectively. Therefore, Fluidigm C1 and
inDrop require vastly different cell numbers to reach the same level
of accuracy in DE analysis, and inDrop generally needs more cells
than Fluidigm C1. This result is reasonable, since inDrop is a tag-
based protocol that is advantageous in capturing more cells but dis-
advantageous in measuring each cell accurately, compared with the
full-length protocol Fluidigm C1. Second, under the same protocol,
the optimal cell number depends on the transcriptome similarity of
the two cell states. For instance, with Smart-seq2, 512 cells need to
be sequenced per state to maximize the recall in identifying DE genes
between two dendrocyte subtypes, but only 256 cells per state are
needed when dendrocytes are compared with monocytes
(Supplementary Fig. S9). If the goal is to maximize the F2 score, the
optimal cell number for comparing the two dendrocyte subtypes
remains 512 per state, but the number reduces to 128 for comparing
dendrocytes with monocytes. It is worth noting that the optimal cell
number for both comparisons becomes 64, the smallest candidate
cell number, when the criterion is the precision or the true negative
rate (Supplementary Table S3). The reason is that only the genes
with strong DE signals are detectable with a small sample size (cell
number) in any statistical testing. Hence, with a reasonable lower
bound on the cell number, the DE genes detected at a smaller cell
number have a higher precision. Unlike the precision, the largest re-
call in DE analysis is mostly achieved at a medium to large cell num-
ber. In all the experimental designs we evaluated, the recall rate of
DE genes first increases with the cell number and then decreases
after reaching a peak (Fig. 2 and Table S3). These results demon-
strate the trade-off between the cell number and the cell-wise library
size in scRNA-seq experiments. A combination of a small cell num-
ber and a large cell-wise library size ensures the identification of the
DE genes with strong DE signals (i.e. achieving a high precision
rate), but the small cell number may prohibit the detection of the DE
genes with small to medium DE signals (i.e. sacrificing the recall
rate). On the other hand, a combination of a reasonably large cell
number and a small cell-wise library size increases the recall rate in
(a)
(b)
Fig. 2. Power analysis for DE studies comparing astrocytes and oligodendrocytes scenario (1). The thresholds on the FDRs to identify DE genes are denoted in the
color legends. The table summarizes the optimal cell number according to each measure. (a) The Fluidigm C1 protocol and (b) the inDrop protocol
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detecting DE genes but compromises the precision rate due to high
dropout rates (Supplementary Fig. S10). We also performed the DE
analysis by replacing the two-sample t-test with an scRNA-seq DE
method MAST (Finak et al., 2015) (Supplementary Table S4). The
optimal cell number remains 64 per state when the criterion is the
precision. The optimal cell numbers defined by the recall have small
differences from the t-test results, but the scale and trend remain
largely consistent.
In scenario (2), the constraint is the total sequencing depth of
one experiment with at least two cell states, and the goal is to deter-
mine the optimal total cell number for that experiment given a cri-
terion in DE analysis. ScDesign simulates a new count matrix of
each cell state based on a real count matrix from the same state,
with pre-specified total sequencing depth, total cell number and cell
proportions of the two cell states of interest. We applied scDesign to
evaluate the designs of 12 example experiments (Supplementary
Table S5). In every experiment, we set the sequencing depth to 100
million reads and considered six cell numbers: 512, 1024, 2048,
4096, 8192 and 16 384. We estimated the cell proportions of the
two cell states from the corresponding real data (Supplementary
Table S5). In practical applications of scDesign, the cell state pro-
portions can be inferred from pilot studies, public data or literature
(Gierahn et al., 2017; Macosko et al., 2015).
In contrast to scenario (1), the optimal total cell number in scen-
ario (2) depends on an additional factor: the cell state proportions,
aside from the technical and biological factors we have discussed.
The two cell states of interest may present in various proportions de-
pending on biological conditions and experimental protocols, and
larger cell state proportions in general reduce the demand of a larger
total cell number. For example, the estimated cell state proportions
of astrocytes and oligodendrocytes in a human brain sample are
19.2% and 14.9%, respectively (Darmanis et al., 2015), and 1024
cells are needed to maximize the recall with Fluidigm C1
(Supplementary Fig. S11). In a mouse visual cortex sample, how-
ever, the estimated proportions of the same two cell types are 8.8%
and 13.1%, respectively, and 16 384 cells are required to achieve
the highest recall with inDrop (Supplementary Fig. S11). Given an
experimental protocol, the optimal total cell number depends on
both the two cell state proportions and the magnitude of gene ex-
pression differences between the two cell states. For example, the
proportions of CD4 cells, CD8 cells and B cells in a human periph-
eral blood mononuclear sample are 17.2%, 10.2% and 7.3%, re-
spectively (Gierahn et al., 2017). Two important facts about this
experiment are: first, the proportion of CD8 cells is higher than the
proportion of B cells; second, the magnitude of gene expression
differences is larger between CD4 and B cells than between CD4
and CD8 cells. With the Seq-Well protocol, the DE analysis of CD4
versus B cells only needs 4096 cells to achieve the highest F1 score.
On the other hand, the DE analysis of CD4 versus CD8 requires 16
384 cells to maximize the F1 score (Supplementary Fig. S12). To fur-
ther assess the effects of cell state proportions on DE analysis, we
synthesized CD4 and B cells with multiple hypothetical cell propor-
tions: 10%;20%; 30% and 40% (Supplementary Fig. S13), among
which the mixture of 40% B cells and 20  30% CD4 cells led to
the minimum cell number required to maximize the recall and preci-
sion. Determining the optimal cell state proportions given a total
cell number is especially useful when the cell states of interest can be
enriched by fluorescence-activated cell sorting (Jaitin et al., 2014) or
flow cytometry (Yen-Rei et al., 2016) before the sequencing step.
3.3 scDesign demonstrates reproducibility across
studies
In addition to evaluating the results of scDesign across different cell
types and scRNA-seq protocols, we also analyzed the experimental
designs of the same cell types and protocols but different datasets, in
attempt to assess the reproducibility of scDesign.
First, we applied scDesign to optimize the pairwise DE analysis
between the oligodendrocyte precursor cells (OPCs) and three other
brain cell types: differentiation-committed oligodendrocyte precur-
sors (COPs), myelin-forming oligodendrocytes (MFOs) and newly
formed oligodendrocytes (NFOs). Two real datasets were collected
for each cell type, and the two datasets were generated using the
Fluidigm C1 protocol but from different brain regions: dorsal horn
and hypothalamus (Marques et al., 2016). We applied scDesign in
scenario (1), assuming a total sequencing depth of 50 million reads
for each cell type. In each experiment, we assumed that the libraries
of the two cell types have the same number of cells, and we consid-
ered five candidate cell numbers per cell type: 64 128, 256 512 and
1024. The experimental design based on the two brain regions lead
to highly consistent results. Both designs show that in a DE analysis
between OPCs and COPs, the optimal number of each cell type is 64
if selected by precision or true negative rate, 512 by F2 score and
1024 by recall or F1 score (Fig. 3); to better compare OPCs and
MFOs or NFOs, the optimal number of each cell type is 64 if
selected by precision, recall or true negative rate, 128 by F2 score
and 64 by F1 score (Supplementary Fig. S14). In fact, not only do
the two designs identify the same optimal cell number in each case,
but they also reveal highly consistent trends about how DE accuracy
changes as the number of sequenced cells increases (Fig. 3 and
Supplementary Fig. S14). This example implies the reproducibility
of scDesign when taking input data from biological replicates.
Second, we applied scDesign to optimize the pairwise DE ana-
lysis between three retina cell types: muller glia, amacrine and rods.
Two real datasets were collected for each cell type, and the two
datasets were generated using the Drop-seq protocol in two inde-
pendent studies (Macosko et al., 2015; Shekhar et al., 2016). We
applied scDesign in scenario (1), assuming a total sequencing depth
of 100 million reads for each cell type. In each experiment, we
assumed that the libraries of the two cell types have the same num-
ber of cells and considered six candidate cell numbers per cell type:
64, 128, 256, 512, 1024 and 2048. The experimental design based
on the single-cell studies lead to highly similar results
(Supplementary Fig. S15). As in the first example, both designs iden-
tified the same optimal cell number regardless of the DE criterion
used. The only exception was in the comparison between the muller
glia and rods: using the Macosko et al. data, the best cell number is
Fig. 3. Reproducibility of scDesign based on data from different brain regions.
The DE studies compare OPCs and COPs based on scRNA-seq data from two
brain regions: dorsal horn and hypothalamus. When identifying the DE
genes, the threshold set on the FDR rate is 1010. The y-axis of each line are
divided by the maximum value of that line for normalization
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512 by F1 score and 1024 by F2 score, while using the Shekhar et al.
data, the best cell number is 1024 by F1 score and 512 by F2 score.
Such discrepancy is not suprising since we only evaluated a few can-
didate cell numbers, and the two input datasets inevitably differ in
qualities as they came from two studies. Overall, this example dem-
onstrates the reproducibility of scDesign when taking input data
from independent studies to design scRNA-seq experiments.
3.4 scDesign assists scRNA-seq method development
In addition to assisting single-cell experimental design, scDesign can
also simulate scRNA-seq data to benchmark various computational
methods for differential gene expression analysis, single cell cluster-
ing analysis, gene expression dimension reduction, etc. Due to excess
zeros resulting from dropout events and the fact that each gene’s ex-
pression level in each cell is only measured once, the ground truth of
individual genes’ expression levels in single cells cannot be accurate-
ly estimated from scRNA-seq data. Also, cellular identities of indi-
vidual cells are difficult to pre-determine in most experiments.
Lacking the aforementioned ground truth encumbers the develop-
ment of computational methods to decipher information from
scRNA-seq data. Direct evaluation of computational methods relies
on experimental validation, which is often unavailable for computa-
tionalists, and indirect interpretation from downstream analysis is
used instead as a not-so-ideal substitute. Empowered by its ability to
generate synthetic scRNA-seq data that well mimic real scRNA-seq
data and have ground truth information, scDesign provides a flex-
ible framework to benchmark computational methods for various
scRNA-seq data analysis tasks.
We first demonstrated the application of scDesign to evaluating
DE methods. We considered a baseline DE method, i.e. the two-
sample t-test, and four DE methods [MAST (Finak et al., 2015),
SCDE (Kharchenko et al., 2014), DESeq2 (Love et al., 2014) and
edgeR (Robinson et al., 2010)] specifically designed for scRNA-seq
data. Here both DESeq2 and edgeR denote their single-cell-adapted
versions, where gene expression values are weighted by the weights
estimated from a zero inflated Negative Binomial model before the
statistical testing step (Van den Berge et al., 2017) . We evaluated
scDesign using real scRNA-seq data of six cell types: dendrocytes
(Smart-seq2, 63.6% zero count), oligodendrocytes (Fluidigm C1,
62.9% zero count), interneurons (inDrop, 75.3% zero counts), ret-
inal ganglions (Drop–seq, 78.3% zero counts), enterocytes (10x
Genomics, 82.0% zero counts) and natural killer cells (Seq-Well,
88.0% zero counts) (Supplementary Table S1). Based on the real
data of each cell type, we simulated a pair of count matrices, with
one matrix representing the given cell type and the other including
up-regulated and down-regulated genes (Supplementary Material).
In the first setting, we set the percentage of DE genes to 5% and
sampled the fold changes of those DE genes’ expression values uni-
formly from the interval ½2; 5. Then we evaluated the performance
of the five DE methods by comparing the areas under their preci-
sion–recall curves (Supplementary Fig. S16). With Smart-seq2 and
Fluidigm C1, MAST and SCDE were the only two methods that
achieved better accuracy than the two-sample t-test, but overall the
three methods had comparable precision and recall. With inDrop
and 10x Genomics, edgeR became the best DE method, followed by
MAST and SCDE. With Drop-seq and Seq-Well, the most accurate
method was SCDE, and the baseline two-sample t-test had poor per-
formance. These simulation results suggest that scRNA-seq data
from the 10x, inDrop, Drop-seq and Seq-Well protocols need more
specialized statistical modeling in the DE analysis, compared with
Smart-seq2 and Fluidigm C1. In the second setting, we set the
percentage of up-regulated and down-regulated genes in each com-
parison to 10% and sampled the fold changes of these DE genes uni-
formly from the interval ½4; 5. Since the magnitude of fold changes
increased, the DE methods overall demonstrated improved accuracy
(Supplementary Fig. S17), but the relative accuracy of the five DE
methods was consistent with that under the first setting.
We next demonstrated the application of scDesign to comparing
dimension reduction methods. We considered four methods: princi-
pal component analysis (PCA), t-distributed stochastic neighbor
embedding (tSNE) (Maaten and Hinton, 2008), independent com-
ponent analysis (ICA) (Hyva¨rinen and Oja, 2000) and ZINB-WaVE
(Risso et al., 2018). We evaluated scDesign based on the same real
scRNA-seq data used in the comparison of DE methods. Based on
the real data of each cell type, we simulated a set of synthetic count
matrices, representing multiple cell states following a differentiation
path (Supplementary Material). For the Smart-seq2 and Fluidigm
C1 protocols, we simulated four cell states with two states each hav-
ing 80 cells and the other two each having 50 cells. For the other
four protocols, we simulated five cell states with two states each
having 300 cells and the other three each having 100 cells. In each
case, we first simulated the cell state at the starting point of differen-
tiation based on the real data, and then we simulated each of the
three subsequent cell states with 1% of up-regulated and down-
regulated genes from its previous state. In addition, we sampled the
fold changes of those DE genes’ expression values uniformly from
½2;5. Among the four dimension reduction methods, ZINB-WaVE
had the best performance in grouping cells into biologically mean-
ingful clusters based on the C1 data, followed by the tSNE method
(Supplementary Fig. S18). Based on the Smart-Seq2 data, PCA had
the best performance in the 2D space, followed by ZINB-WaVE
(Supplementary Fig. S19). However, the comparison results were
different for droplet-based protocols. The tSNE method led to the
most accurate cell clusters for the Drop-seq, inDrop, 10x and Seq-
Well protocols, followed by ICA or PCA (Supplementary Figs S20–
S23). In addition to the clustering performance, another factor
worth noting is that PCA, ICA and ZINB-WaVE generate compar-
able cellcell distances after dimension reduction, but tSNE does
not. The above results demonstrate the capacity of scDesign in help-
ing developers evaluate competing computational methods for the
same purpose (e.g. DE analysis or dimension reduction), and in
assisting users to select the appropriate method for analyzing
scRNA-seq data from a specific protocol.
4 Discussion
The scRNA-seq technologies have become an essential tool for
studying various biological and biomedical problems, but one unre-
solved challenge is how to balance the trade-off between exploring
the depth or breadth of transcriptome information in experimental
design. We introduce scDesign, the first statistical and computation-
al simulator that enables rational and practical scRNA-seq experi-
mental design. By integrating statistical assumptions and real
scRNA-seq datasets from public repositories into its generative
framework, scDesign is able to mimic real experimental processes
and simulate synthetic scRNA-seq datasets that well capture gene
expression characteristics in real data. In addition, scDesign is a
flexible and reproducible simulator that is capable of modeling
protocol-specific scRNA-seq data generated under multiple biologic-
al and experimental conditions. We conducted a comprehensive
comparison of scDesign and four other scRNA-seq simulation meth-
ods based on datasets from 17 different cell types and 6
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experimental protocols. The comparison suggests that scDesign gen-
erates synthetic data with the largest resemblance to real scRNA-seq
data regardless of cell types and protocols.
Using its simulated data, scDesign performs power analysis on
differential gene expression analysis to provide a quantitative and
objective standard for designing future experiments. In the context
of differential gene expression analysis between two cell states,
scDesign suggests an optimal cell number given a fixed sequencing
depth, in the trade-off between a deeper sequencing of a smaller
number of cells or a shallower sequencing of a larger number of
cells. Specifically, we demonstrated the application of scDesign in
two scenarios, where cells from the two states are sequenced as two
separate libraries or as one pooled library. We evaluated the experi-
mental designs for 14 and 12 scRNA-seq studies under the two scen-
arios, respectively. Our results for the first time demonstrate how
the optimal experimental design for DE analysis depends on the
scRNA-seq protocol and the intra- and inter-cell state transcriptome
heterogeneity. In addition, our results revealed a general phenom-
enon that a deeper sequencing of a smaller number of cells leads to a
higher precision in DE analysis. In contrast to the precision, maxi-
mizing the recall of DE analysis requires finding a balance between
the cell-wise sequencing depth and the cell number, because our
results show that the recall first increases and then decreases as we
increase the cell number with the total sequencing depth fixed.
ScDesign enables researchers to design effective scRNA-seq experi-
ments without pre-experimental costs in an objective manner, for
example, guided by the expected power in downstream DE analysis.
In addition, we demonstrate that scDesign leads to reproducible ex-
perimental design for target cell states given data generated in differ-
ent studies.
Aside from enhancing future experimental design, another main
contribution of scDesign is to assist computational method develop-
ment for scRNA-seq. Since large-scale benchmark data are not yet
available in the field, computationalists typically rely on scRNA-seq
datasets from public repositories to test and evaluate new methods
and algorithms. However, quality control and normalization of real
data are themselves ongoing research questions, making the evalu-
ation results in many method papers not comparable nor reprodu-
cible (McCarthy et al., 2017; Ziegenhain et al., 2017). To tackle this
challenge, scDesign allows users to generate synthetic scRNA-seq
datasets with user-specified experimental protocols, sequencing
depths, cell states, cell numbers, as well as pre-specified DE genes.
Given that scDesign generates synthetic data that have known truth
and well mimic real data, users can leverage its synthetic data to
comprehensively evaluate computational and statistical methods in
a flexible, reproducible and comparable way. For example, we com-
pared five DE methods (the two-sample t-test, MAST, SCDE,
DESeq2 and edgeR) and four dimension reduction methods (PCA,
tSNE, ICA and ZINB-WaVE) using synthetic data generated by
scDesign. Those comparison results provide useful guidance for
researchers to select the most appropriate computational method to
analyze real data.
We expect scDesign to assist scRNA-seq experimental design for
a vast array of available experimental protocols. ScDesign incorpo-
rates real scRNA-seq data into its statistical framework to make
flexible decisions based on the protocol and cell states used in the
target study. If the real data of the two cell states are not generated
from the same experiment, it is recommended to first correct the
batch effect before applying scDesign (Butler et al., 2018; Haghverdi
et al., 2018). To extend scDesign’s ability to evaluate experimental
designs for cell states whose scRNA-seq data are not yet publicly
available, a future direction is to incorporate bulk RNA-seq data of
the same type as a surrogate to estimate the gene expression parame-
ters. Otherwise, pilot experiments need to be conducted to collect
data for experimental design, which is also a widely adopted prac-
tice (Chatterjee et al., 2018). Another future extension of scDesign is
to find the optimal design in the context of other types of down-
stream analyses besides the differential gene expression analysis,
such as the detection of novel cell sub-types or the recovery of tem-
poral transcriptome trajectories (Dumitrascu et al., 2018). For in-
stance, we may jointly learn the proportions and the gene expression
profiles of multiple cell states from real scRNA-seq data and use
them as input into our simulation framework to evaluate how the
power of detecting rare cell types changes with experimental param-
eters. Given time-series scRNA-seq data, the scDesign framework
can be modified to conduct ANOVA or more advanced statistical
analysis to objectively select cell numbers for multiple time points. It
is also possible to generalize the simulation framework of scDesign
to account for more complex trajectories in the cell differentiation
process (Cannoodt et al., 2019; Papadopoulos et al., 2019). We ex-
pect scDesign to be an effective bioinformatic tool that assists ra-
tional scRNA-seq experiment design and benchmarks competing
scRNA–seq computational methods based on specific research
goals.
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